Prof. R. Manjunatha Kini graduated from the University of Mysore, Mysore, India, and completed postdoctoral training at Kyushu University, Fukuoka, Japan, and Virginia Commonwealth University, Richmond, Virginia, USA, before joining National University of Singapore (NUS) in 1994. He became a Professor at the Department of Biological Sciences in 2005. He was a Joint Professor and Adjunct Senior Principal Investigator at the Singapore Eye Research Institute, Singapore. He held adjunct positions at Virginia Commonwealth University in Richmond, Virginia; the University of Oxford in Oxford; and the University of South Australia in Adelaide. He was the Co-founder of ProScience, Richmond, Virginia, and the Founder and Chief Scientific Officer of ProTherapeutics, Singapore. He was the Editor-in-Chief of Toxin Reviews for 10 years and is now the Editor Emeritus.  He serves as Associate Editor and member of the editorial boards of several international journals. His main research focus is “From Toxins to Therapeutics”, where he identifies novel bioactive proteins from venoms or saliva, determines their modes of action, and designs potential drug leads based on their structure.